# Black Diamond Therapeutics, Inc.: Form 8-K, filed Jun 30, 2023

- Company: [Black Diamond Therapeutics, Inc.](/companies/bdtx.md) (CIK 1701541)
- Form: 8-K
- Filed: 2023-06-30
- Accepted by EDGAR: Jun 30, 2023, 16:03 ET
- Period: 2023-06-29
- Accession: 0001104659-23-077061
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1701541/000110465923077061/tm2320300d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701541/000110465923077061/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701541/000110465923077061/tm2320300d1_8k.htm

Filed Jun 30, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-077061. Last ingested by Listed: Nov 10, 2026, 16:37 ET. No prices; not investment advice.